0 XP   0   0   0

BIOFIL CHEMICALS & PHARMACEUTICALS LTD.
Buy, Hold or Sell?

Should you buy, hold or sell BIOFIL CHEMICALS & PHARMACEUTICALS LTD.?

I guess you are interested in BIOFIL CHEMICALS & PHARMACEUTICALS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse BIOFIL CHEMICALS & PHARMACEUTICALS LTD.

Let's start. I'm going to help you getting a better view of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is BIOFIL CHEMICALS & PHARMACEUTICALS LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how BIOFIL CHEMICALS & PHARMACEUTICALS LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value BIOFIL CHEMICALS & PHARMACEUTICALS LTD.. The closing price on 2023-01-30 was INR50.25 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
BIOFIL CHEMICALS & PHARMACEUTICALS LTD. Daily Candlestick Chart
BIOFIL CHEMICALS & PHARMACEUTICALS LTD. Daily Candlestick Chart
Summary









1. Valuation of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.




Current price per share

INR50.25

2. Growth of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.




Is BIOFIL CHEMICALS & PHARMACEUTICALS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$2m$1.9m$87.1k4.2%

How much money is BIOFIL CHEMICALS & PHARMACEUTICALS LTD. making?

Current yearPrevious yearGrowGrow %
Making money$85.9k$152.6k-$66.7k-77.7%
Net Profit Margin3.1%3.5%--

How much money comes from the company's main activities?

3. Financial Health of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.




Comparing to competitors in the Pharmaceuticals industry




  Industry Rankings (Pharmaceuticals)  


Richest
#38 / 54

Most Revenue
#33 / 54

Most Profit
#33 / 54


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of BIOFIL CHEMICALS & PHARMACEUTICALS LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit BIOFIL CHEMICALS & PHARMACEUTICALS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare BIOFIL CHEMICALS & PHARMACEUTICALS LTD. to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 3.1% means that ₹0.03 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 3.1%. The company is making a profit. +1
  • The TTM is 3.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.1%TTM3.1%0.0%
TTM3.1%YOY3.5%-0.4%
TTM3.1%5Y3.3%-0.2%
5Y3.3%10Y5.0%-1.7%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1%3.3%-0.2%
TTM3.1%6.9%-3.8%
YOY3.5%9.9%-6.4%
5Y3.3%6.3%-3.0%
10Y5.0%6.7%-1.7%
1.1.2. Return on Assets

Shows how efficient BIOFIL CHEMICALS & PHARMACEUTICALS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare BIOFIL CHEMICALS & PHARMACEUTICALS LTD. to the Pharmaceuticals industry mean.
  • 3.7% Return on Assets means that BIOFIL CHEMICALS & PHARMACEUTICALS LTD. generated ₹0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 3.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.7%TTM3.7%0.0%
TTM3.7%YOY3.7%0.0%
TTM3.7%5Y2.9%+0.9%
5Y2.9%10Y3.7%-0.9%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7%0.8%+2.9%
TTM3.7%1.3%+2.4%
YOY3.7%1.5%+2.2%
5Y2.9%1.4%+1.5%
10Y3.7%1.4%+2.3%
1.1.3. Return on Equity

Shows how efficient BIOFIL CHEMICALS & PHARMACEUTICALS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare BIOFIL CHEMICALS & PHARMACEUTICALS LTD. to the Pharmaceuticals industry mean.
  • 4.1% Return on Equity means BIOFIL CHEMICALS & PHARMACEUTICALS LTD. generated ₹0.04 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 4.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.1%TTM4.1%0.0%
TTM4.1%YOY7.7%-3.5%
TTM4.1%5Y5.4%-1.3%
5Y5.4%10Y6.9%-1.5%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1%1.5%+2.6%
TTM4.1%2.0%+2.1%
YOY7.7%3.0%+4.7%
5Y5.4%2.1%+3.3%
10Y6.9%2.0%+4.9%

1.2. Operating Efficiency of BIOFIL CHEMICALS & PHARMACEUTICALS LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient BIOFIL CHEMICALS & PHARMACEUTICALS LTD. is operating .

  • Measures how much profit BIOFIL CHEMICALS & PHARMACEUTICALS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare BIOFIL CHEMICALS & PHARMACEUTICALS LTD. to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.8%-2.8%
5Y2.8%10Y5.4%-2.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ--5.6%+5.6%
TTM-0.5%-0.5%
YOY-6.2%-6.2%
5Y2.8%5.1%-2.3%
10Y5.4%5.2%+0.2%
1.2.2. Operating Ratio

Measures how efficient BIOFIL CHEMICALS & PHARMACEUTICALS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 1.83 means that the operating costs are ₹1.83 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 1.829. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.829. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.829TTM1.8290.000
TTM1.829YOY1.874-0.045
TTM1.8295Y1.816+0.013
5Y1.81610Y1.767+0.050
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8291.342+0.487
TTM1.8291.276+0.553
YOY1.8741.169+0.705
5Y1.8161.149+0.667
10Y1.7671.178+0.589

1.3. Liquidity of BIOFIL CHEMICALS & PHARMACEUTICALS LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if BIOFIL CHEMICALS & PHARMACEUTICALS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 6.23 means the company has ₹6.23 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 6.231. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.231. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.231TTM6.2310.000
TTM6.231YOY1.400+4.830
TTM6.2315Y2.296+3.935
5Y2.29610Y2.144+0.152
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2312.205+4.026
TTM6.2312.010+4.221
YOY1.4002.125-0.725
5Y2.2961.812+0.484
10Y2.1441.786+0.358
1.3.2. Quick Ratio

Measures if BIOFIL CHEMICALS & PHARMACEUTICALS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare BIOFIL CHEMICALS & PHARMACEUTICALS LTD. to the Pharmaceuticals industry mean.
  • A Quick Ratio of 4.84 means the company can pay off ₹4.84 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 4.840. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.840. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.840TTM4.8400.000
TTM4.840YOY1.053+3.786
TTM4.8405Y1.867+2.973
5Y1.86710Y1.772+0.095
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8401.118+3.722
TTM4.8401.152+3.688
YOY1.0531.091-0.038
5Y1.8671.007+0.860
10Y1.7720.869+0.903

1.4. Solvency of BIOFIL CHEMICALS & PHARMACEUTICALS LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of BIOFIL CHEMICALS & PHARMACEUTICALS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare BIOFIL CHEMICALS & PHARMACEUTICALS LTD. to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.10 means that BIOFIL CHEMICALS & PHARMACEUTICALS LTD. assets are financed with 10.1% credit (debt) and the remaining percentage (100% - 10.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.101. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.101. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.101TTM0.1010.000
TTM0.101YOY0.515-0.414
TTM0.1015Y0.431-0.330
5Y0.43110Y0.429+0.002
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1010.381-0.280
TTM0.1010.379-0.278
YOY0.5150.417+0.098
5Y0.4310.398+0.033
10Y0.4290.399+0.030
1.4.2. Debt to Equity Ratio

Measures if BIOFIL CHEMICALS & PHARMACEUTICALS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare BIOFIL CHEMICALS & PHARMACEUTICALS LTD. to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 11.3% means that company has ₹0.11 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.113. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.113. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.113TTM0.1130.000
TTM0.113YOY1.061-0.948
TTM0.1135Y0.926-0.813
5Y0.92610Y0.891+0.034
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1130.586-0.473
TTM0.1130.598-0.485
YOY1.0610.598+0.463
5Y0.9260.671+0.255
10Y0.8910.664+0.227

2. Market Valuation of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings BIOFIL CHEMICALS & PHARMACEUTICALS LTD. generates.

  • Above 15 is considered overpriced but always compare BIOFIL CHEMICALS & PHARMACEUTICALS LTD. to the Pharmaceuticals industry mean.
  • A PE ratio of 134.68 means the investor is paying ₹134.68 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.:

  • The EOD is 117.090. Seems overpriced? -1
  • The MRQ is 134.683. Seems overpriced? -1
  • The TTM is 134.683. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD117.090MRQ134.683-17.593
MRQ134.683TTM134.6830.000
TTM134.683YOY86.062+48.621
TTM134.6835Y60.977+73.706
5Y60.97710Y52.921+8.056
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD117.09040.785+76.305
MRQ134.68351.661+83.022
TTM134.68351.419+83.264
YOY86.06264.495+21.567
5Y60.97756.903+4.074
10Y52.92161.712-8.791
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of BIOFIL CHEMICALS & PHARMACEUTICALS LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 239.398. Seems overpriced? -1
  • The TTM is 239.398. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ239.398TTM239.3980.000
TTM239.398YOY83.691+155.707
TTM239.3985Y109.304+130.093
5Y109.30410Y109.3040.000
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ239.3980.015+239.383
TTM239.3980.036+239.362
YOY83.6910.327+83.364
5Y109.3040.144+109.160
10Y109.3040.144+109.160

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of BIOFIL CHEMICALS & PHARMACEUTICALS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 5.59 means the investor is paying ₹5.59 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of BIOFIL CHEMICALS & PHARMACEUTICALS LTD.:

  • The EOD is 4.857. Neutral. Compare to industry.
  • The MRQ is 5.586. Seems overpriced? -1
  • The TTM is 5.586. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD4.857MRQ5.586-0.730
MRQ5.586TTM5.5860.000
TTM5.586YOY6.624-1.037
TTM5.5865Y3.132+2.454
5Y3.13210Y2.908+0.224
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD4.8572.248+2.609
MRQ5.5862.690+2.896
TTM5.5863.050+2.536
YOY6.6243.185+3.439
5Y3.1322.899+0.233
10Y2.9082.711+0.197
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BIOFIL CHEMICALS & PHARMACEUTICALS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4350.4350%0.766-43%0.509-14%1.724-75%
Book Value Growth--1.0441.0440%1.084-4%1.058-1%1.058-1%
Book Value Per Share--10.34710.3470%9.911+4%9.176+13%8.947+16%
Book Value Per Share Growth--1.0441.0440%1.084-4%1.058-1%1.058-1%
Current Ratio--6.2316.2310%1.400+345%2.296+171%2.144+191%
Debt To Asset Ratio--0.1010.1010%0.515-80%0.431-77%0.429-76%
Debt To Equity Ratio--0.1130.1130%1.061-89%0.926-88%0.891-87%
Dividend Per Share----0%-0%-0%-0%
Eps--0.4290.4290%0.763-44%0.504-15%0.604-29%
Eps Growth--0.5630.5630%1.028-45%1.076-48%1.076-48%
Free Cash Flow Per Share---0.178-0.1780%0.334-153%0.125-242%0.124-244%
Free Cash Flow Per Share Growth---0.533-0.5330%0.651-182%1.211-144%1.211-144%
Free Cash Flow To Equity Per Share---0.178-0.1780%0.334-153%0.043-513%0.045-498%
Free Cash Flow To Equity Per Share Growth---0.533-0.5330%2.017-126%0.340-257%0.340-257%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--1.685--------
Intrinsic Value_10Y_min--1.330--------
Intrinsic Value_1Y_max---0.104--------
Intrinsic Value_1Y_min---0.101--------
Intrinsic Value_3Y_max---0.103--------
Intrinsic Value_3Y_min---0.101--------
Intrinsic Value_5Y_max--0.147--------
Intrinsic Value_5Y_min--0.118--------
Net Profit Margin--0.0310.0310%0.035-10%0.033-6%0.050-37%
Operating Margin----0%-0%0.028-100%0.054-100%
Operating Ratio--1.8291.8290%1.874-2%1.816+1%1.767+4%
Pb Ratio4.857-15%5.5865.5860%6.624-16%3.132+78%2.908+92%
Pe Ratio117.090-15%134.683134.6830%86.062+56%60.977+121%52.921+154%
Peg Ratio--239.398239.3980%83.691+186%109.304+119%109.304+119%
Price Per Share50.250-15%57.80057.8000%65.650-12%30.492+90%27.733+108%
Price To Total Gains Ratio115.405-15%132.744132.7440%85.751+55%60.481+119%50.699+162%
Profit Growth--0.5630.5630%1.028-45%1.076-48%1.076-48%
Quick Ratio--4.8404.8400%1.053+359%1.867+159%1.772+173%
Return On Assets--0.0370.0370%0.0370%0.029+31%0.0370%
Return On Equity--0.0410.0410%0.077-46%0.054-23%0.069-40%
Revenue Growth--0.6260.6260%1.204-48%1.181-47%1.181-47%
Total Gains Per Share--0.4350.4350%0.766-43%0.509-14%1.724-75%
Total Gains Per Share Growth--0.5690.5690%1.010-44%1.040-45%1.040-45%
Usd Book Value--2071037.1002071037.1000%1983879.300+4%1836810.660+13%1790954.766+16%
Usd Book Value Change Per Share--0.0050.0050%0.009-43%0.006-14%0.021-75%
Usd Book Value Per Share--0.1270.1270%0.122+4%0.113+13%0.110+16%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0050.0050%0.009-44%0.006-15%0.007-29%
Usd Free Cash Flow---35645.400-35645.4000%66936.600-153%25069.860-242%20891.550-271%
Usd Free Cash Flow Per Share---0.002-0.0020%0.004-153%0.002-242%0.002-244%
Usd Free Cash Flow To Equity Per Share---0.002-0.0020%0.004-153%0.001-513%0.001-498%
Usd Price Per Share0.618-15%0.7110.7110%0.807-12%0.375+90%0.341+108%
Usd Profit--85903.20085903.2000%152692.200-44%100860.000-15%120830.561-29%
Usd Revenue--2753022.9002753022.9000%4397299.200-37%3033460.440-9%2803698.482-2%
Usd Total Gains Per Share--0.0050.0050%0.009-43%0.006-14%0.021-75%
 EOD+3 -2MRQTTM+0 -0YOY+11 -275Y+10 -2910Y+9 -30

3.2. Fundamental Score

Let's check the fundamental score of BIOFIL CHEMICALS & PHARMACEUTICALS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15117.090
Price to Book Ratio (EOD)Between0-14.857
Net Profit Margin (MRQ)Greater than00.031
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.840
Current Ratio (MRQ)Greater than16.231
Debt to Asset Ratio (MRQ)Less than10.101
Debt to Equity Ratio (MRQ)Less than10.113
Return on Equity (MRQ)Greater than0.150.041
Return on Assets (MRQ)Greater than0.050.037
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of BIOFIL CHEMICALS & PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.232
Ma 20Greater thanMa 5054.170
Ma 50Greater thanMa 10054.571
Ma 100Greater thanMa 20052.787
OpenGreater thanClose50.650
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets187,322
Total Liabilities18,945
Total Stockholder Equity168,377
 As reported
Total Liabilities 18,945
Total Stockholder Equity+ 168,377
Total Assets = 187,322

Assets

Total Assets187,322
Total Current Assets93,130
Long-term Assets93,130
Total Current Assets
Cash And Cash Equivalents 1,450
Short-term Investments 600
Net Receivables 71,737
Inventory 12,932
Other Current Assets 2,478
Total Current Assets  (as reported)93,130
Total Current Assets  (calculated)89,197
+/- 3,933
Long-term Assets
Long-term Assets  (as reported)94,193
Long-term Assets  (calculated)0
+/- 94,193

Liabilities & Shareholders' Equity

Total Current Liabilities14,947
Long-term Liabilities3,998
Total Stockholder Equity168,377
Total Current Liabilities
Short Long Term Debt 4,647
Accounts payable 5,963
Other Current Liabilities -1
Total Current Liabilities  (as reported)14,947
Total Current Liabilities  (calculated)10,609
+/- 4,338
Long-term Liabilities
Long-term Liabilities  (as reported)3,998
Long-term Liabilities  (calculated)0
+/- 3,998
Total Stockholder Equity
Total Stockholder Equity (as reported)168,377
Total Stockholder Equity (calculated)0
+/- 168,377
Other
Capital Stock162,738
Common Stock Shares Outstanding 16,274
Net Debt 3,197
Net Invested Capital 173,024
Net Working Capital 78,183



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
218,404
241,547
242,130
423,647
332,384
187,322
187,322332,384423,647242,130241,547218,404
   > Total Current Assets 
126,759
149,079
139,188
322,721
234,616
93,130
93,130234,616322,721139,188149,079126,759
       Cash And Cash Equivalents 
3,097
3,745
1,362
2,560
4,405
1,450
1,4504,4052,5601,3623,7453,097
       Short-term Investments 
0
0
0
0
4,308
600
6004,3080000
       Net Receivables 
118,620
131,539
121,927
299,248
172,179
71,737
71,737172,179299,248121,927131,539118,620
       Inventory 
1,663
10,248
11,909
16,921
43,446
12,932
12,93243,44616,92111,90910,2481,663
       Other Current Assets 
3,379
3,394
3,902
3,808
-1
2,478
2,478-13,8083,9023,3943,379
   > Long-term Assets 
91,645
92,468
102,942
100,926
97,769
94,193
94,19397,769100,926102,94292,46891,645
       Property Plant Equipment 
91,645
92,468
102,942
100,926
0
0
00100,926102,94292,46891,645
> Total Liabilities 
91,438
109,873
105,633
274,815
171,093
18,945
18,945171,093274,815105,633109,87391,438
   > Total Current Liabilities 
91,438
109,874
105,633
274,815
167,531
14,947
14,947167,531274,815105,633109,87491,438
       Short Long Term Debt 
14,281
15,586
16,373
11,920
4,298
4,647
4,6474,29811,92016,37315,58614,281
       Accounts payable 
70,952
91,417
85,834
259,175
158,520
5,963
5,963158,520259,17585,83491,41770,952
       Other Current Liabilities 
5,860
2,514
3,197
3,539
0
-1
-103,5393,1972,5145,860
   > Long-term Liabilities 
0
-1
0
-1
3,562
3,998
3,9983,562-10-10
> Total Stockholder Equity
126,965
131,674
136,497
148,832
161,291
168,377
168,377161,291148,832136,497131,674126,965
   Common Stock
162,738
162,738
162,738
162,738
0
0
00162,738162,738162,738162,738
   Retained Earnings -330,595-337,681-350,140-362,475-367,298-372,006
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
318,952
318,952
318,952
318,952
0
0
00318,952318,952318,952318,952



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue223,823
Cost of Revenue-194,604
Gross Profit29,21929,219
 
Operating Income (+$)
Gross Profit29,219
Operating Expense-214,773
Operating Income9,050-185,554
 
Operating Expense (+$)
Research Development-
Selling General Administrative1,920
Selling And Marketing Expenses-
Operating Expense214,7731,920
 
Net Interest Income (+$)
Interest Income210
Interest Expense-390
Net Interest Income-196-180
 
Pretax Income (+$)
Operating Income9,050
Net Interest Income-196
Other Non-Operating Income Expenses-
Income Before Tax (EBT)10,1499,050
EBIT - interestExpense = -390
6,984
7,374
Interest Expense390
Earnings Before Interest and Taxes (ebit)-10,539
Earnings Before Interest and Taxes (ebitda)14,814
 
After tax Income (+$)
Income Before Tax10,149
Tax Provision-3,165
Net Income From Continuing Ops6,9846,984
Net Income6,984
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-196
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
SBFM.NASDAQ
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SBFM.NASDAQ.

SBFM.NASDAQ Daily Candlestick Chart
SANW.NASDAQ
3 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of SANW.NASDAQ.

SANW.NASDAQ Daily Candlestick Chart
RZB.NYSE
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RZB.NYSE.

RZB.NYSE Daily Candlestick Chart
RYU.NYSE ARC
4 minutes ago

I found you a Golden Cross on the daily chart of RYU.NYSE ARC.

RYU.NYSE ARC Daily Candlestick Chart
RRGB.NASDAQ
6 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of RRGB.NASDAQ.

RRGB.NASDAQ Daily Candlestick Chart
RNAZ.NASDAQ
9 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RNAZ.NASDAQ.

RNAZ.NASDAQ Daily Candlestick Chart
SBITOP.INDX
10 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SBITOP.INDX.

SBITOP.INDX Daily Candlestick Chart
BETXT.INDX
11 minutes ago

I found you a Golden Cross on the daily chart of BETXT.INDX.

BETXT.INDX Daily Candlestick Chart
RGF.NASDAQ
12 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RGF.NASDAQ.

RGF.NASDAQ Daily Candlestick Chart
REED.NASDAQ
14 minutes ago

I found you a Golden Cross on the daily chart of REED.NASDAQ.

REED.NASDAQ Daily Candlestick Chart
RCUS.NYSE
15 minutes ago

I found you a Death Cross on the daily chart of RCUS.NYSE.

RCUS.NYSE Daily Candlestick Chart
RAIN.NASDAQ
19 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of RAIN.NASDAQ.

RAIN.NASDAQ Daily Candlestick Chart
PZZA.NASDAQ
22 minutes ago

I found you a Golden Cross on the daily chart of PZZA.NASDAQ.

PZZA.NASDAQ Daily Candlestick Chart
PTLC.BATS
24 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PTLC.BATS.

PTLC.BATS Daily Candlestick Chart
WWY1.F
33 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of WWY1.F.

WWY1.F Daily Candlestick Chart
W7V.F
35 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of W7V.F.

W7V.F Daily Candlestick Chart
UZQ.F
37 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of UZQ.F.

UZQ.F Daily Candlestick Chart
TG1N.F
39 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of TG1N.F.

TG1N.F Daily Candlestick Chart
SZL.F
40 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SZL.F.

SZL.F Daily Candlestick Chart
S1K2.F
43 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of S1K2.F.

S1K2.F Daily Candlestick Chart
RYQ.F
43 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RYQ.F.

RYQ.F Daily Candlestick Chart
RHRD.F
45 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of RHRD.F.

RHRD.F Daily Candlestick Chart
PX0.F
46 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PX0.F.

PX0.F Daily Candlestick Chart
PH6.F
47 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PH6.F.

PH6.F Daily Candlestick Chart
OCD1.F
49 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of OCD1.F.

OCD1.F Daily Candlestick Chart